Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

X-linked inhibitor of apoptosis (XIAP) deficiency, caused by mutations in BIRC4, is an immunodeficiency associated with immune dysregulation and a highly variable clinical presentation. Current diagnostic screening tests such as flow cytometry for XIAP expression or lymphocyte apoptosis assays have significant limitations. Based on recent evidence that XIAP is essential for nucleotide-binding and oligomerization domains (NOD)1/2 signalling, we evaluated the use of a simple flow cytometric assay assessing tumour necrosis factor (TNF) production of monocytes in response to NOD2 stimulation by muramyl dipeptides (L18-MDP) for the functional diagnosis of XIAP deficiency. We investigated 12 patients with XIAP deficiency, six female carriers and relevant disease controls. Irrespective of the diverse clinical phenotype, the extent of residual protein expression or the nature of the mutation, the TNF response was severely reduced in all patients. On average, L18-MDP induced TNF production in 25% of monocytes from healthy donors or female carriers, while fewer than 6% of monocytes responded in affected patients. Notably, the assay clearly discriminated affected patients from disease controls with other immunodeficiencies accompanied by lymphoproliferation, hypogammaglobulinaemia or inflammatory bowel disease. Functional testing of the NOD2 signalling pathway is an easy, fast and reliable assay in the diagnostic evaluation of patients with suspected XIAP deficiency.

Original publication

DOI

10.1111/cei.12306

Type

Journal article

Journal

Clin Exp Immunol

Publication Date

06/2014

Volume

176

Pages

394 - 400

Keywords

Crohn's disease, MDP, NOD2, XIAP, XLP, Acetylmuramyl-Alanyl-Isoglutamine, Adolescent, Adult, Aged, Case-Control Studies, Child, Child, Preschool, Female, Flow Cytometry, Humans, Immunologic Deficiency Syndromes, Immunophenotyping, Infant, Leukocytes, Mononuclear, Male, Middle Aged, Mutation, Nod2 Signaling Adaptor Protein, Phenotype, T-Lymphocytes, Tumor Necrosis Factors, X-Linked Inhibitor of Apoptosis Protein, Young Adult